DELIVERY ORDER
ActiveHT942626FE055
Department of Defense › Defense Health Agency › DEFENSE HEALTH AGENCY
$100K
obligated · signed 5 months ago
NOVEL BISPECIFIC BROAD SPECTRUM NANOBODY
Performance timeline
Start
Jul 1, 2026
End
Jun 30, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Jun 30, 2027
EITR BIOLOGICS, INC.
Contract HT942626FE055
UEI
HX49LZLY32G5
Parent Company
EITR BIOLOGICS, INC.
Capabilities & Certifications
Headquarters Location
Congressional District: 51
Current Obligation
$100,000
Base + Exercised Options
$100,000
Total Ceiling Value
$100,000
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSC
GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
Place of Performance
Congressional District: 51
Awarding Agency
Funding Agency
Top-tier agency
Defense Health Agency
Sub-tier agency
ARMY MED RES INST OF DESEASE - MM
Office
Contract Vehicle
HT942523D0011
IDCDepartment of Defense
Award type: SINGLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.